A Comparison of Two Methods for Quantifying Blood-Brain Barrier Disruption, with Application to Multiple Sclerosis (S45.006)

Conclusions: Dual-echo dynamic susceptibility contrast scanning is a clinically feasible approach for quantification of BBB changes in multiple sclerosis. When using single-echo T2*-weighted imaging to do permeability analysis, longer echo times will likely perform better than shorter echo times.Disclosure: Dr. Chen has nothing to disclose. Dr. Selvaganesan has nothing to disclose. Dr. Reich has received research support from Vertex Pharmaceuticals. Dr. Nair has nothing to disclose. Dr. Leigh has nothing to disclose.
Source: Neurology - Category: Neurology Authors: Tags: MRI and OCT Outcomes in Multiple Sclerosis Source Type: research